Latanoprost and Left ventricular dysfunction - a phase IV clinical study of FDA data

Summary:

Left ventricular dysfunction is reported as a side effect among people who take Latanoprost (latanoprost), especially for people who are female, 60+ old, also take Metformin, and have Thyroid diseases.

The phase IV clinical study analyzes which people have Left ventricular dysfunction when taking Latanoprost. It is created by eHealthMe based on reports of 32,842 people who have side effects when taking Latanoprost from the FDA, and is updated regularly.

What is Latanoprost?

Latanoprost has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 33,249 Latanoprost users. Check the latest studies of Latanoprost.

What is Left ventricular dysfunction?

Left ventricular dysfunction is found to be associated with 890 drugs and 792 conditions by eHealthMe. Check the latest studies of Left ventricular dysfunction.

On Jul, 21, 2026

32,842 people reported to have side effects when taking Latanoprost.
Among them, 15 people (0.05%) have Left ventricular dysfunction.

Could Latanoprost cause Left ventricular dysfunction?

Among these 15 people:

What is the gender of people who have Left ventricular dysfunction when taking Latanoprost? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Left ventricular dysfunction when taking Latanoprost? *

What are other drugs people take besides Latanoprost? *

What are other side effects people have besides Left ventricular dysfunction? *

Cardiac Failure: 11 people, 73.33%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 9 people, 60.00%
Atrioventricular Block Complete (heart block complete): 9 people, 60.00%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 9 people, 60.00%
Laboratory Test Abnormal: 2 people, 13.33%
Carotid Arteriosclerosis (plaque deposition in artery): 2 people, 13.33%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 13.33%
Orthopnea (shortness of breath (dyspnea) when lying down): 2 people, 13.33%
Prostatic Specific Antigen Increased: 2 people, 13.33%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 1 person, 6.67%

What are the existing conditions these people have? *

High Blood Cholesterol: 2 people, 13.33%
Prostatic Specific Antigen Decreased: 2 people, 13.33%
Pain: 2 people, 13.33%
Thyroid Diseases: 2 people, 13.33%
Folate Deficiency (lack of folic acid): 1 person, 6.67%
Cardiac Failure Congestive: 1 person, 6.67%
Constipation: 1 person, 6.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 6.67%
Depression: 1 person, 6.67%
Diabetic Nephropathy (diabetic kidney disease): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Latanoprost and have Left ventricular dysfunction?

- Check whether Left ventricular dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Latanoprost:

Latanoprost (33,249 reports)

Browse all side effects of Latanoprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Left ventricular dysfunction:

Left ventricular dysfunction (890 drugs)

Browse all the conditions that are associated with Left ventricular dysfunction:

Left ventricular dysfunction (792 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Latanoprost) and Latanoprost (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.